Factors prohibiting progression to prostanoid therapy in patients with pulmonary arterial hypertension and CTEPH who remain in functional class III or above despite maximal oral therapy
28 August 2016 (14:00 - 18:00)
Organised by:
Abstract
Slides
About the speaker
Royal Brompton Hospital, London (United Kingdom of Great Britain & Northern Ireland)
15 More presentations in this session
Access the full session
The Event
ESC Congress 2016
28 August 2016
14:00 CET
